Commentary

Clinical Pharmacology & Therapeutics (2007) 82, 366–370. doi:10.1038/sj.clpt.6100363

Beyond Genomics

C T Dollery1

1GlaxoSmithKline, Harlow, UK

Correspondence: CT Dollery, (colin.dollery@gsk.com)

Extra navigation

.

naturejobs

ADVERTISEMENT